Le Lézard
Classified in: Health
Subjects: PDT, CSR, SCZ

Central Connecticut Virtual 60 Strong Calendar Contest: Celebrate Life After 60!


HARTFORD, Conn., June 25, 2020 /PRNewswire/ -- You, or someone you know, could be featured as a "pin up" in the 2021 Central Connecticut 60 Strong calendar, an exclusive calendar showcasing inspirational "60 somethings" and highlighting Central Connecticut events and activities. In addition to appearing in the calendar, winners receive celebrity treatment with a virtual kick-off party, professional photo shoot and compensation for their modeling time.

Anyone age 18 or older can nominate a friend or family member - age 60 to 69 - who has achieved remarkable levels of fitness, pursued a new hobby or helped those in need. The candidate might be "giving back", fighting a chronic condition or caring for someone who is.  

Here's how it works:

Central Connecticut 60 Strong candidates must be between ages of 60 and 69 on Sept. 1, 2020, and a resident of the following Connecticut counties: Hartford, Middlesex, Tolland, Litchfield; and Hampden and Hampshire counties in Massachusetts.

Celebrity judges will virtually select 12 winners who exemplify how life after sixty can be a vibrant and active time. Contestants are judged on health/fitness/wellness, community involvement, volunteerism and why they are inspirational to others.

Winners must be available Thursday, August 27, through Saturday, August 29, 2020 for virtual party and photo shoot. Questions? Email us at [email protected]. All proceeds from calendar sales benefit CT Foodshare to support response efforts to hunger.

About Starling Senior Care Advantage
Starling Physicians is proud to announce the Central Connecticut 60 Strong contest in conjunction with the launch of Starling Senior Care Advantage, a program designed to provide seamless and greater coordination of care for their senior patients.

SOURCE Starling Senior Care Advantage


These press releases may also interest you

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: